Novel humanized mouse model of mucosal immunity

新型人源化小鼠粘膜免疫模型

基本信息

  • 批准号:
    10591854
  • 负责人:
  • 金额:
    $ 29.16万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2023
  • 资助国家:
    美国
  • 起止时间:
    2023-01-01 至 2024-12-31
  • 项目状态:
    已结题

项目摘要

PROJECT SUMMARY Although humanized mice have been successfully used for in vivo studies of HIV infection, cancer and immunotherapies, human naïve and adaptive immune responses remain suboptimal, with limited cross-reactivity between murine and human cytokines considered as a key contributing factor. As a result, the human mucosal immune system is not fully developed, and several components are missing, including the presence of human lung epithelial cells in their natural lung environment. To address these research gaps, we propose a combined genetic and cellular editing approach to develop the next generation of humanized mice for studies of human mucosal immunity. Our approach is structured in two aims: in Aim 1, we will construct and credential hNSGF- SGM3-IL6-TSLP-TSLPR mice for human immune cell development. We will generate mice expressing a complete human TSLP receptor and examine engraftment with human hematopoietic progenitor cells (HPCs) by measuring cellular composition of immune cells in the bone marrow, spleen, gut, airways, lungs, and blood. To examine human immune function, we will use a mucosal formulation of influenza vaccine (Flumist) as an immune trigger and antigen source as we have done in the past and analyze cytokine responses in the blood and spleen; human cell migration to mucosal sites, spleen, and bone marrow; and induction of vaccine antigen- specific T and B cells in the spleen. In Aim 2, we will construct and credential humanized airway epithelium in hNSGF-SGM3-IL6-TSLP-TSLPR mice. We will examine the development of human airway epithelium upon transplant of human bronchial epithelial progenitor cells in NSGF-SGM3-IL6-TSLP-TSLPR mice (humanized or not with HPCs from the same donor) by tissue immunofluorescence staining of human-specific targets including HLA class I. To establish the functionality of human airway epithelial cells, we will challenge mice with live influenza virus and measure the induction of species-specific alarmins including IL-33; type I interferon signature in human epithelial cells as a measure of their functionality in vivo, as well as tissue composition and attraction of human immune cells to human airway epithelium. Our hypothesis is that a complete TSLP signaling pathway and human epithelial cells will improve human mucosal immunity in humanized mice by facilitating the crosstalk between stromal cells and immune cells. This model can then be used for i. mucosal vaccine development, and ii. studies of other respiratory viruses including SARS-CoV-2, which requires human-specific receptors to establish infection. Thus, once credentialed, our model will lay the groundwork for future mechanistic studies of mucosal immunity in vivo in the context of genetically variable donors as well as enable studies of mucosal adjuvants, allergens, vaccines, and biologicals.
项目总结 尽管人源化小鼠已经成功地用于艾滋病毒感染的体内研究,但癌症和 免疫疗法、人类幼稚免疫反应和适应性免疫反应仍然是次优的,交叉反应有限。 鼠和人的细胞因子之间被认为是一个关键的促成因素。因此,人类的粘膜 免疫系统没有完全发育,缺少几个组成部分,包括人类的存在 肺上皮细胞在其自然的肺环境中。为了解决这些研究差距,我们提出了一个综合的 基因和细胞编辑方法开发用于人类研究的下一代人源化小鼠 粘膜免疫。我们的方法有两个目标:在目标1中,我们将构造和认证hNSGF- SGM3-IL6-TSLP-TSLPR小鼠用于人类免疫细胞发育。我们将产生小鼠表达一种 人TSLP受体的完整及其与人造血祖细胞的植入检测 通过测量骨髓、脾、肠道、呼吸道、肺和血液中免疫细胞的细胞组成。 为了检测人类的免疫功能,我们将使用一种粘膜配方的流感疫苗(Flumist)作为 免疫触发和抗原源,分析血液中的细胞因子反应 和脾;人类细胞迁移到粘膜部位、脾和骨髓;以及疫苗抗原的诱导- 脾中的特异性T细胞和B细胞。在目标2中,我们将构建人源化的呼吸道上皮,并在 HNSGF-SGM3-IL6-TSLP-TSLPR小鼠。我们将研究人类呼吸道上皮细胞的发育。 人支气管上皮祖细胞在NSGF-SGM3-IL6-TSLP-TSLPR小鼠体内的移植(人源化或人源化) 不是来自同一捐赠者的HPC)通过组织免疫荧光染色的人类特异性靶标,包括 为了建立人类呼吸道上皮细胞的功能,我们将用活的小鼠 流感病毒和包括IL-33在内的物种特异性警报的诱导;I型干扰素签名 人体上皮细胞作为体内功能以及组织组成和吸引力的衡量标准 人类免疫细胞对人类呼吸道上皮细胞的作用。我们的假设是,一个完整的TSLP信号通路 而人类上皮细胞将通过促进串扰提高人源化小鼠的人类黏膜免疫力 在基质细胞和免疫细胞之间。该模型随后可用于I.粘膜疫苗的开发,以及 二、对其他呼吸道病毒的研究,包括SARS-CoV-2,它需要人类特异性受体来 确定感染。因此,一旦获得认证,我们的模型将为未来的机械研究奠定基础 在遗传可变供体背景下的活体粘膜免疫以及使粘膜研究成为可能 佐剂、过敏原、疫苗和生物制品。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Anna Karolina Palucka其他文献

Anna Karolina Palucka的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Anna Karolina Palucka', 18)}}的其他基金

Modulation of Lung Immune Responses to Viral Infection
调节肺部对病毒感染的免疫反应
  • 批准号:
    10413443
  • 财政年份:
    2021
  • 资助金额:
    $ 29.16万
  • 项目类别:
Modulation of Viral Antigen Presentation in the Lung
肺部病毒抗原呈递的调节
  • 批准号:
    10436633
  • 财政年份:
    2021
  • 资助金额:
    $ 29.16万
  • 项目类别:
Modulation of Viral Antigen Presentation in the Lung
肺部病毒抗原呈递的调节
  • 批准号:
    10370726
  • 财政年份:
    2020
  • 资助金额:
    $ 29.16万
  • 项目类别:
Modulation of Lung Immune Responses to Viral Infection
调节肺部对病毒感染的免疫反应
  • 批准号:
    10265638
  • 财政年份:
    2020
  • 资助金额:
    $ 29.16万
  • 项目类别:
Modulation of Viral Antigen Presentation in the Lung
肺部病毒抗原呈递的调节
  • 批准号:
    10618415
  • 财政年份:
    2020
  • 资助金额:
    $ 29.16万
  • 项目类别:
Modulation of Lung Immune Responses to Viral Infection
调节肺部对病毒感染的免疫反应
  • 批准号:
    10399136
  • 财政年份:
    2020
  • 资助金额:
    $ 29.16万
  • 项目类别:
Modulation of Lung Immune Responses to Viral Infection
调节肺部对病毒感染的免疫反应
  • 批准号:
    10579861
  • 财政年份:
    2019
  • 资助金额:
    $ 29.16万
  • 项目类别:
Sample Procurement and Management Core
采购和管理核心示例
  • 批准号:
    10579866
  • 财政年份:
    2019
  • 资助金额:
    $ 29.16万
  • 项目类别:
Modulation of Viral Antigen Presentation in the Lung
肺部病毒抗原呈递的调节
  • 批准号:
    10113525
  • 财政年份:
    2019
  • 资助金额:
    $ 29.16万
  • 项目类别:
Modulation of Lung Immune Responses to Viral Infection
调节肺部对病毒感染的免疫反应
  • 批准号:
    10113511
  • 财政年份:
    2019
  • 资助金额:
    $ 29.16万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 29.16万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 29.16万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 29.16万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 29.16万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 29.16万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 29.16万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 29.16万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 29.16万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 29.16万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 29.16万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了